IN VIVO AND IN VITRO EFFECTS OF ARTEMISININ GROUP OF DRUGS ON TRYPANOSOMOSIS IN MICE
DOI:
https://doi.org/10.51406/jnset.v10i1.1338Keywords:
Artemether, artesunate, diminazene aceturate, in vitro and in vivo, trypanosomosis.Abstract
This study was done to study the effect of artemisinin groups of drugs on mice experimentally infected with the protozoan Trypanosoma brucei and on Trypanosoma brucei invitro. Commercial artesunate and artemether were used with diminazene aceturate serving as control. It was discovered that artemether administration resulted into seven days of aparasitaemia of trypanosomosis in vivo and reduced motility of the trypanosomes in vitro. There was synergistic effect in the action of artesunate and diminazene aceturate. In vitro analysis gave a similar result in that the trypanosome were found to be sensitive to artemether with an MIC of 0.6µl, artesunate with berenil combination and the artemether treatment group 2.5µM. The implication of these results is discussed and advice is given on the potential adaptation of artesunate for treatment of trypanosomosis and planting of Artemisia annua tree in the country.
Â
References
Bich, N.N., De Vries P.J., Van Thien H., Phong, T.H, Hung, L.N., Eggelte, T.E., Anh, T.K., Kager., P.A. 1996. Efficacy and tolerance of artemisinin in short combination regimens for the treatment of uncomplicated falciparum malaria. American Journal of Tropical Medicine and Hygiene, 55: 438-443.
Biobaku, K.T., Ajayi, O.L., Ajagbona., O.P., Omotainse, S.O. 2008. Effects of magnesium chloride and diminazene aceturate on the pathogenicity of trypanosoma brucei infection in rats. Vom Journal of Veterinary science, 5(1).
China Cooperative Research Group on Qinghaosu and its Derivatives as Antimalarials. 1982. Chemical Studies on quighaosu (artemisinine) J. Tradit. Chin. Med. 2:3-8.
Farrel, N.P., Williamson, J., Mclaren, D.J.M. 1984. Trypanocidal and antitumour activity of platinum metal and platinum metal drug dual function complexes. Biochemistry and Pharmacology, 33: 961-971.
Francois, C., Louis, L., Pere, S., Veerle, L., Phillipe, B. 2005 Option for field diagnosis of human African trypanosomiasis. Clinical Microbiology Reviews. 133-136.
Herbert, W.J., Lumsden, W.R.H. 1976 Trypanosoma brucei: a rapid matching method for estimating host parasitaemia. Experimental parasitology 40: 427-431
Kinnamon, K.E, Steck, E.A, Rane, D.S. 1989. Activity of antitumour drugs against African Trypanosomes. Antimicrobial agents and Chemotherapy 33:881-885
Kuzoe, F.A.S 1993. Current situation of African trypanosomiasis. Acta. Trop 54: 153-162
Leach, T.M., Robert, C.J. 1981. Present status of chemotherapy and chemoprophylaxis of animal trypanosomiasis in the Eastern Hemisphere. Pharmacology Therapeutics. 13: 91-147
Mbwambo, H.A, Mella, P.N.P, Lekaki, K.A. 1998. Berenil (diminazene aceturate) –resistant Trypanosoma congolense in cattle under natural tsetse challenge at Kibaha, Tanzania. Acta tropica 45: 239-244.
Mcintosh H.M., Oliaro, P. 1998. Treatment of severe malaria with artemisinin derivatives: a systemic review of randomized controlled trials. Med. Trop., 58: 61-2.
Rottcher, D., Schillinger, D. 1985. Multiple drug resistance in Trypanosoma vivax in Tana River District of Kenya. Vet Rec., 117: 557-558
Trouiler, P., Olliaro, P., Torreele, E, Orbinski, J, Lang, R.., Ford, N. 2002. Drug development for neglected diseases, a deficient market and public health policy failure
White, N.J. 1994. Artemisinin: current status. Trans. R. Soc. Trop. Med. Hyg. 8 (Suppl. 1) 53- 54. World Health Organisation. 2006 Human African trypanosomiasis (sleeping sickness): epidemiological update. Weekly Epidemiology Record. 81: 69-80
Yuliya, V.M., Sanjev Kirshna, Richard, K.H., John C.M. 2007. Artemisinins inhibit Trypanosoma cruzi and trypanosome brucei rhodesiense in vitro growth. Antimicrobial agents and Chemotherapy. p 1852-1854.
